IGF-1LR3

Growth Hormone / RecoveryPerformance / Body Composition

IGF-1LR3 1 mg Research Profile & Reconstitution Reference

RESEARCH PROFILE

Explore the compound

IdentityFormulationsResearchReferences

Quick Facts

Alternate NamesIGF-1 LR3

Molecular FormulaNot listed

Molecular WeightNot listed

Research ClassGrowth Hormone / Recovery, Performance / Body Composition

Research StatusPreclinical research

Evidence ClassificationAnimal / in-vivo preclinical

Half-LifeNot established

Physical Formlyophilized

Mechanism of Action

Supports growth-hormone axis signaling, including GH pulse or IGF-pathway research depending on compound ^[1].
Commonly discussed for recovery, sleep quality, lean-mass support, and body-composition goals tied to GH biology ^[1].
Associated with muscle, connective-tissue, and metabolic research endpoints in PubMed-indexed literature ^[1].
Official trial and NIH database searches document the broader clinical/research landscape for this axis ^[2]^[3].

Research Applications & Context

Community-reported protocol schedules.

Research Dosage Information

Reported research quantities and their source context. These are not recommendations, and source status varies.

Scroll the table horizontally to read every column. Select a row to inspect it in the calculator.

Weeks 1-2: 20 mcg Once daily. Weeks 1-2. Weeks 3-4: 40 mcg Once daily. Weeks 3-4. Weeks 5-8: 50 mcg Once daily. Weeks 5-8.

Research dosage rows for IGF-1LR3
Phase	Reported Amount	Frequency	Draw Units	Cycle	Notes
Weeks 1-2	20 mcg	Once daily	Select a vial	Weeks 1-2	Community-reported protocol.
Weeks 3-4	40 mcg	Once daily	Select a vial	Weeks 3-4	Community-reported protocol.
Weeks 5-8	50 mcg	Once daily	Select a vial	Weeks 5-8	Community-reported protocol.

Dosing Protocol & Schedule

Community-reported research schedules, not clinically validated protocols. Select a reported scenario and duration to calculate mathematical quantities.

Period	Research Dose	Frequency	Total Injections	Total amount	Volume per entry	U-100 equivalent

Strength changes affect volume and supplies, not the underlying community-reported quantities. Figures exceeding the selected syringe capacity are flagged; they are not instructions for splitting administrations.

Plan a Regimen Schedule

Save the selected research protocol to your private calendar. Scheduled entries never create Dose Logs.

Vial variant Reported protocol

Reconstitution Calculator

Select the vial strength you are examining. The reference chart displays examples, not recommended preparation volumes or validated protocols.

Available vial strengths

Vial strength / variant

Reported research protocol

Reconstitution Calculation

Research compound profile

Choose a compound to see the vial variants in the catalog.

Calculation direction

Quantity in vialQuantity in vialQuantity in vial unit

Reconstitution AgentReconstitution AgentEnter the measured final solution volume. Actual reconstitution agent added may differ due to displacement.

Desired DoseDesired DoseDesired Dose unitMathematical research draw quantity; not a recommended dose.

Syringe Capacity

Formulation status

Calculated equivalent

—units

Draw Amount (mg / mcg): —
Draws per vial: —
Concentration: —
Draw Volume: —
Syringe Capacity: —
Final Solution Volume: —

Theoretical only. Confirm actual concentrations and measurement uncertainty.

U-100 volume reference—

Magnified graduation view

Magnified reading follows the calculated volume.

—

Illustrative capacity-specific U-100 volume scale. Actual increments vary by instrument. Biological IU is a separate dimension.

Side-by-Side Research Comparison

Compare two independent configurations

Compare compatible research quantities, concentrations and U-100 volume equivalents. The values below are independent of the main calculator.

Configuration A

Vial quantity Vial unit Final solution volume (mL) Draw Amount Draw unit Syringe Capacity

Enter values and compare.

Concentration: —
Draw Volume: —
U-100 equivalent: —

Configuration B

Vial quantity Vial unit Final solution volume (mL) Draw Amount Draw unit Syringe Capacity

Enter values and compare.

Concentration: —
Draw Volume: —
U-100 equivalent: —

Mathematical comparison only, not a recommended dose or preferred configuration. Concentrations compare only when quantity dimensions are compatible.

Private calculation history

Reconstitution Reference Chart

Hypothetical volume comparisons for the selected vial. No particular volume is endorsed, and vial capacity, solubility, excipients and product-specific instructions are not established by this table.

Example volume	Calculated concentration	Calculator
1 mL	—
2 mL	—
3 mL	—
4 mL	—
5 mL	—

Choose a compatible dry vial to see reference concentrations.

Research-only mathematical comparisons; not instructions to compound, prepare, or administer peptides. Community-reported protocols are not clinically validated by inclusion here.

Supplies Needed — Estimate

Select a vial strength and an example reconstitution volume below. Counts use only the checked, computable rows above; they are not product-specific sterility, compatibility, or stability guidance.

Total Injections—

Minimum vials by mass—

Total Syringes—

Reconstitution agent—

10 mL reconstitution-agent bottles—

Alcohol Swabs (2 per entry)—

Total quantity—

Select a compatible vial and volume below to view quantities.

Educational and entertainment purposes only. Research use only; not for human or animal administration. Pad counts assume two per Total entry; syringe counts include additional containers where a single entry exceeds the selected syringe capacity. Vial totals assume full theoretical recovery and do not account for dead volume, spoilage, asepsis, expiration, potency, route, or beyond-use dating. These figures are not a recommended supplies list for an actual procedure.

Published References (0 identified)

A recorded identifier identifies a publication; it does not establish that its claims have been independently verified.

Research indexes & other source links

Searches, registries and unverified source records are discovery resources, not verified published studies.

PubMed.gov biomedical literature: IGF-1LR3 View source ↗ PubMed index/search · Source link recorded; claim verification separate
ClinicalTrials.gov study registry: IGF-1LR3 View source ↗ ClinicalTrials.gov registry/search · Source link recorded; claim verification separate
NIH/NCBI all-databases search: IGF-1LR3 View source ↗ NCBI database/search · Source link recorded; claim verification separate
PubChem / NIH compound record search: IGF-1LR3 View source ↗ PubChem database/search · Source link recorded; claim verification separate